BMY Annual SG&A
$7.77 B
-$42.00 M-0.54%
31 December 2023
Summary:
As of January 22, 2025, BMY annual selling, general & administrative expenses is $7.77 billion, with the most recent change of -$42.00 million (-0.54%) on December 31, 2023. During the last 3 years, it has risen by +$111.00 million (+1.45%). BMY annual SG&A is now -0.54% below its all-time high of $7.81 billion, reached on December 31, 2022.BMY Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY Quarterly SG&A
$1.98 B
+$55.00 M+2.85%
30 September 2024
Summary:
As of January 22, 2025, BMY quarterly selling, general & administrative expenses is $1.98 billion, with the most recent change of +$55.00 million (+2.85%) on September 30, 2024. Over the past year, it has dropped by -$90.00 million (-4.34%). BMY quarterly SG&A is now -27.12% below its all-time high of $2.72 billion, reached on December 31, 2020.BMY Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY TTM SG&A
$76.61 B
-$12.12 B-13.66%
30 September 2024
Summary:
As of January 22, 2025, BMY TTM selling, general & administrative expenses is $76.61 billion, with the most recent change of -$12.12 billion (-13.66%) on September 30, 2024. Over the past year, it has increased by +$68.83 billion (+885.67%). BMY TTM SG&A is now -46.06% below its all-time high of $8.38 billion, reached on March 31, 2024.BMY TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -0.5% | -4.3% | +885.7% |
3 y3 years | +1.4% | -4.3% | +885.7% |
5 y5 years | +70.8% | -4.3% | +885.7% |
BMY Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -0.5% | +1.1% | -16.2% | +12.5% | -31.0% | at low |
5 y | 5-year | -0.5% | +59.6% | -27.1% | +23.5% | -46.1% | at low |
alltime | all time | -0.5% | +105.1% | -27.1% | +519.7% | -46.1% | +1567.5% |
Bristol-Myers Squibb Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $1.98 B(+2.9%) | $8.35 B(-0.2%) |
June 2024 | - | $1.93 B(-18.5%) | $8.37 B(-0.1%) |
Mar 2024 | - | $2.37 B(+14.2%) | $8.38 B(+7.8%) |
Dec 2023 | $7.77 B(-0.5%) | $2.07 B(+3.5%) | $7.77 B(-2.4%) |
Sept 2023 | - | $2.00 B(+3.6%) | $7.96 B(+0.9%) |
June 2023 | - | $1.93 B(+9.8%) | $7.89 B(+1.9%) |
Mar 2023 | - | $1.76 B(-22.2%) | $7.75 B(-0.9%) |
Dec 2022 | $7.81 B(+1.6%) | $2.27 B(+17.4%) | $7.81 B(-1.1%) |
Sept 2022 | - | $1.93 B(+8.0%) | $7.90 B(+1.8%) |
June 2022 | - | $1.79 B(-2.4%) | $7.76 B(-1.2%) |
Mar 2022 | - | $1.83 B(-22.2%) | $7.86 B(+2.1%) |
Dec 2021 | $7.69 B(+0.4%) | $2.35 B(+31.7%) | $7.69 B(-4.6%) |
Sept 2021 | - | $1.79 B(-5.0%) | $8.06 B(+1.0%) |
June 2021 | - | $1.88 B(+13.0%) | $7.97 B(+3.3%) |
Mar 2021 | - | $1.67 B(-38.8%) | $7.72 B(+0.8%) |
Dec 2020 | $7.66 B(+57.3%) | $2.72 B(+59.5%) | $7.66 B(+14.8%) |
Sept 2020 | - | $1.71 B(+4.8%) | $6.67 B(+10.8%) |
June 2020 | - | $1.63 B(+1.4%) | $6.02 B(+10.1%) |
Mar 2020 | - | $1.61 B(-7.4%) | $5.47 B(+12.3%) |
Dec 2019 | $4.87 B(+7.0%) | $1.73 B(+64.4%) | $4.87 B(+8.9%) |
Sept 2019 | - | $1.05 B(-2.0%) | $4.47 B(-1.1%) |
June 2019 | - | $1.08 B(+7.0%) | $4.52 B(-1.2%) |
Mar 2019 | - | $1.01 B(-24.7%) | $4.58 B(+0.6%) |
Dec 2018 | $4.55 B(-4.2%) | $1.34 B(+21.0%) | $4.55 B(+0.4%) |
Sept 2018 | - | $1.10 B(-2.4%) | $4.53 B(-1.3%) |
June 2018 | - | $1.13 B(+15.4%) | $4.59 B(-1.2%) |
Mar 2018 | - | $980.00 M(-25.5%) | $4.65 B(-2.2%) |
Dec 2017 | $4.75 B(-4.6%) | $1.32 B(+13.2%) | $4.75 B(-3.0%) |
Sept 2017 | - | $1.16 B(-2.0%) | $4.90 B(0.0%) |
June 2017 | - | $1.19 B(+9.4%) | $4.90 B(-1.5%) |
Mar 2017 | - | $1.08 B(-25.8%) | $4.97 B(-0.1%) |
Dec 2016 | $4.98 B(-0.4%) | $1.46 B(+25.8%) | $4.98 B(-1.7%) |
Sept 2016 | - | $1.16 B(-7.9%) | $5.07 B(-1.2%) |
June 2016 | - | $1.26 B(+15.9%) | $5.13 B(+1.8%) |
Mar 2016 | - | $1.09 B(-29.7%) | $5.04 B(+0.7%) |
Dec 2015 | $5.00 B(-12.2%) | $1.55 B(+26.6%) | $5.00 B(-10.0%) |
Sept 2015 | - | $1.22 B(+4.5%) | $5.55 B(-0.1%) |
June 2015 | - | $1.17 B(+10.9%) | $5.56 B(-0.2%) |
Mar 2015 | - | $1.06 B(-49.8%) | $5.57 B(-2.2%) |
Dec 2014 | $5.70 B(+11.7%) | $2.10 B(+71.3%) | $5.70 B(+15.3%) |
Sept 2014 | - | $1.23 B(+3.8%) | $4.94 B(+0.3%) |
June 2014 | - | $1.18 B(-0.1%) | $4.93 B(-3.5%) |
Mar 2014 | - | $1.18 B(-12.2%) | $5.11 B(+0.0%) |
Dec 2013 | $5.10 B(-1.4%) | $1.35 B(+11.4%) | $5.10 B(-3.1%) |
Sept 2013 | - | $1.21 B(-11.0%) | $5.26 B(-0.6%) |
June 2013 | - | $1.36 B(+15.0%) | $5.29 B(+2.6%) |
Mar 2013 | - | $1.18 B(-21.7%) | $5.16 B(-0.3%) |
Dec 2012 | $5.17 B(+0.1%) | $1.51 B(+21.7%) | $5.17 B(-0.0%) |
Sept 2012 | - | $1.24 B(+1.1%) | $5.18 B(+0.3%) |
June 2012 | - | $1.23 B(+2.7%) | $5.16 B(-1.2%) |
Mar 2012 | - | $1.20 B(-20.8%) | $5.22 B(+1.0%) |
Dec 2011 | $5.17 B(+10.2%) | $1.51 B(+23.4%) | $5.17 B(+4.3%) |
Sept 2011 | - | $1.22 B(-5.3%) | $4.96 B(+2.1%) |
June 2011 | - | $1.29 B(+13.2%) | $4.86 B(+2.9%) |
Mar 2011 | - | $1.14 B(-12.1%) | $4.72 B(+0.6%) |
Dec 2010 | $4.69 B(-10.0%) | $1.30 B(+15.7%) | $4.69 B(-4.2%) |
Sept 2010 | - | $1.12 B(-2.9%) | $4.90 B(-1.7%) |
June 2010 | - | $1.16 B(+4.0%) | $4.98 B(-1.8%) |
Mar 2010 | - | $1.11 B(-26.1%) | $5.07 B(-2.7%) |
Dec 2009 | $5.21 B(-2.6%) | $1.50 B(+24.4%) | $5.21 B(+17.0%) |
Sept 2009 | - | $1.21 B(-3.1%) | $4.46 B(-7.5%) |
June 2009 | - | $1.25 B(-0.4%) | $4.82 B(-6.5%) |
Mar 2009 | - | $1.25 B(+68.0%) | $5.15 B(-3.7%) |
Dec 2008 | $5.35 B(-15.3%) | $746.00 M(-52.5%) | $5.35 B(-20.3%) |
Sept 2008 | - | $1.57 B(-0.9%) | $6.72 B(+1.9%) |
June 2008 | - | $1.58 B(+9.1%) | $6.59 B(+2.0%) |
Mar 2008 | - | $1.45 B(-31.1%) | $6.46 B(+0.8%) |
Dec 2007 | $6.32 B(+2.9%) | $2.11 B(+46.2%) | $6.41 B(+8.7%) |
Sept 2007 | - | $1.44 B(-1.0%) | $5.90 B(-0.5%) |
June 2007 | - | $1.46 B(+4.0%) | $5.93 B(-1.3%) |
Mar 2007 | - | $1.40 B(-12.4%) | $6.01 B(-2.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2006 | $6.14 B(-4.9%) | $1.60 B(+8.4%) | $6.14 B(-1.4%) |
Sept 2006 | - | $1.48 B(-3.8%) | $6.22 B(-2.5%) |
June 2006 | - | $1.53 B(0.0%) | $6.38 B(-1.5%) |
Mar 2006 | - | $1.53 B(-9.0%) | $6.49 B(+0.5%) |
Dec 2005 | $6.45 B(+0.4%) | $1.68 B(+3.0%) | $6.45 B(-2.0%) |
Sept 2005 | - | $1.64 B(+0.1%) | $6.58 B(+1.7%) |
June 2005 | - | $1.63 B(+8.8%) | $6.47 B(+1.3%) |
Mar 2005 | - | $1.50 B(-17.3%) | $6.39 B(-0.6%) |
Dec 2004 | $6.43 B(+6.5%) | $1.81 B(+19.0%) | $6.43 B(+2.8%) |
Sept 2004 | - | $1.52 B(-1.5%) | $6.25 B(+0.7%) |
June 2004 | - | $1.55 B(+0.3%) | $6.21 B(+0.7%) |
Mar 2004 | - | $1.54 B(-5.7%) | $6.16 B(+2.1%) |
Dec 2003 | $6.04 B(+14.6%) | $1.64 B(+10.3%) | $6.04 B(+1.6%) |
Sept 2003 | - | $1.48 B(-1.2%) | $5.94 B(+3.7%) |
June 2003 | - | $1.50 B(+6.1%) | $5.73 B(+4.0%) |
Mar 2003 | - | $1.42 B(-8.2%) | $5.51 B(+4.6%) |
Dec 2002 | $5.27 B(+1.4%) | $1.54 B(+21.1%) | $5.27 B(+2.7%) |
Sept 2002 | - | $1.27 B(-0.7%) | $5.13 B(+1.7%) |
June 2002 | - | $1.28 B(+9.5%) | $5.04 B(-2.1%) |
Mar 2002 | - | $1.17 B(-16.5%) | $5.15 B(-2.2%) |
Dec 2001 | $5.19 B(-6.1%) | $1.40 B(+18.2%) | $5.27 B(+1.5%) |
Sept 2001 | - | $1.19 B(-14.7%) | $5.19 B(-3.2%) |
June 2001 | - | $1.39 B(+7.9%) | $5.36 B(-9.0%) |
Mar 2001 | - | $1.29 B(-2.9%) | $5.89 B(-0.8%) |
Dec 2000 | $5.53 B(+3.6%) | $1.33 B(-2.3%) | $5.93 B(-2.7%) |
Sept 2000 | - | $1.36 B(-29.2%) | $6.10 B(+1.6%) |
June 2000 | - | $1.92 B(+43.8%) | $6.00 B(+2.2%) |
Mar 2000 | - | $1.33 B(-10.5%) | $5.87 B(-5.1%) |
Dec 1999 | $5.34 B(+2.6%) | $1.49 B(+18.1%) | $6.19 B(+23.3%) |
Sept 1999 | - | $1.26 B(-29.4%) | $5.02 B(-6.1%) |
June 1999 | - | $1.79 B(+8.4%) | $5.35 B(+2.1%) |
Mar 1999 | - | $1.65 B(+415.6%) | $5.23 B(+0.6%) |
Dec 1998 | $5.20 B(-18.9%) | $320.00 M(-79.8%) | $5.20 B(-22.1%) |
Sept 1998 | - | $1.59 B(-5.3%) | $6.68 B(+1.4%) |
June 1998 | - | $1.68 B(+3.5%) | $6.59 B(+1.0%) |
Mar 1998 | - | $1.62 B(-9.7%) | $6.53 B(+1.7%) |
Dec 1997 | $6.41 B(+9.2%) | $1.79 B(+19.6%) | $6.41 B(+2.9%) |
Sept 1997 | - | $1.50 B(-7.1%) | $6.23 B(+2.5%) |
June 1997 | - | $1.61 B(+7.0%) | $6.08 B(+1.9%) |
Mar 1997 | - | $1.51 B(-6.5%) | $5.97 B(+1.7%) |
Dec 1996 | $5.87 B(+10.4%) | $1.61 B(+19.8%) | $5.87 B(+1.9%) |
Sept 1996 | - | $1.35 B(-10.4%) | $5.76 B(+2.0%) |
June 1996 | - | $1.50 B(+6.5%) | $5.64 B(+2.2%) |
Mar 1996 | - | $1.41 B(-6.1%) | $5.52 B(+3.9%) |
Dec 1995 | $5.32 B(+17.3%) | $1.50 B(+21.8%) | $5.32 B(+3.5%) |
Sept 1995 | - | $1.23 B(-10.7%) | $5.14 B(+4.2%) |
June 1995 | - | $1.38 B(+14.8%) | $4.93 B(+4.1%) |
Mar 1995 | - | $1.20 B(-9.1%) | $4.73 B(+4.5%) |
Dec 1994 | $4.53 B(-24.2%) | $1.32 B(+29.1%) | $4.53 B(-14.4%) |
Sept 1994 | - | $1.02 B(-13.6%) | $5.30 B(-4.5%) |
June 1994 | - | $1.19 B(+18.5%) | $5.55 B(-3.4%) |
Mar 1994 | - | $1.00 B(-52.1%) | $5.74 B(-3.9%) |
Dec 1993 | $5.98 B(-5.6%) | $2.09 B(+63.6%) | $5.98 B(+0.1%) |
Sept 1993 | - | $1.28 B(-7.6%) | $5.97 B(-3.2%) |
June 1993 | - | $1.38 B(+11.7%) | $6.17 B(-1.3%) |
Mar 1993 | - | $1.24 B(-40.6%) | $6.25 B(-1.4%) |
Dec 1992 | $6.34 B(+16.0%) | $2.08 B(+41.3%) | $6.34 B(+8.4%) |
Sept 1992 | - | $1.47 B(+0.6%) | $5.85 B(+3.8%) |
June 1992 | - | $1.46 B(+10.5%) | $5.64 B(+2.5%) |
Mar 1992 | - | $1.32 B(-16.7%) | $5.50 B(+0.7%) |
Dec 1991 | $5.46 B(+8.5%) | $1.59 B(+26.2%) | $5.46 B(+1.6%) |
Sept 1991 | - | $1.26 B(-4.9%) | $5.38 B(+1.4%) |
June 1991 | - | $1.32 B(+2.9%) | $5.30 B(+2.8%) |
Mar 1991 | - | $1.29 B(-14.5%) | $5.16 B(+2.5%) |
Dec 1990 | $5.04 B(-7.6%) | $1.51 B(+27.0%) | $5.04 B(+42.7%) |
Sept 1990 | - | $1.19 B(+0.3%) | $3.53 B(+50.6%) |
June 1990 | - | $1.18 B(+1.6%) | $2.35 B(+101.6%) |
Mar 1990 | - | $1.16 B | $1.16 B |
Dec 1989 | $5.45 B(+26.6%) | - | - |
Dec 1988 | $4.30 B(+13.6%) | - | - |
Dec 1987 | $3.79 B | - | - |
FAQ
- What is Bristol-Myers Squibb annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual SG&A year-on-year change?
- What is Bristol-Myers Squibb quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly SG&A year-on-year change?
- What is Bristol-Myers Squibb TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM SG&A year-on-year change?
What is Bristol-Myers Squibb annual selling, general & administrative expenses?
The current annual SG&A of BMY is $7.77 B
What is the all time high annual SG&A for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual selling, general & administrative expenses is $7.81 B
What is Bristol-Myers Squibb annual SG&A year-on-year change?
Over the past year, BMY annual selling, general & administrative expenses has changed by -$42.00 M (-0.54%)
What is Bristol-Myers Squibb quarterly selling, general & administrative expenses?
The current quarterly SG&A of BMY is $1.98 B
What is the all time high quarterly SG&A for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly selling, general & administrative expenses is $2.72 B
What is Bristol-Myers Squibb quarterly SG&A year-on-year change?
Over the past year, BMY quarterly selling, general & administrative expenses has changed by -$90.00 M (-4.34%)
What is Bristol-Myers Squibb TTM selling, general & administrative expenses?
The current TTM SG&A of BMY is $76.61 B
What is the all time high TTM SG&A for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM selling, general & administrative expenses is $8.38 B
What is Bristol-Myers Squibb TTM SG&A year-on-year change?
Over the past year, BMY TTM selling, general & administrative expenses has changed by +$68.83 B (+885.67%)